(Pediatrics in Review Neo Reviews. 2000;1:e2-e5.)
© 2000 American Academy of Pediatrics
Epidemiology and Risk Factors for the "New" Bronchopulmonary Dysplasia
Eduardo Bancalari, MD*
*
Professor of Pediatrics, Division of
Neonatology, University of Miami School of
Medicine, Miami, FL.
 |
OBJECTIVES
|
|---|
After completing this article, readers should be able to:
- Explain the difference in clinical course between classic
bronchopulmonary dysplasia (BPD) and "new BPD."
- Describe the potential role of inflammation in the pathogenesis
of BPD.
- Describe how patent ductus arteriosus may affect the
development of BPD.
- Delineate the role of infection in the pathogenesis of
BPD.
 |
Introduction
|
|---|
The classic severe form of bronchopulmonary
dysplasia (BPD) described by Northway and colleagues is occurring less
frequently, but there is an increasing number of small preterm infants
who are surviving with a milder form of chronic lung damage (Fig.
1
).
These two forms of chronic lung
disease (CLD) differ not only in their clinical presentation but in
pathogenic mechanisms and long-term consequences.

View larger version (35K):
[in this window]
[in a new window]
|
Figure 1. Incidence of BPD by birthweight among infants weighing
less than 1,500 g born in 1996 through 1998 at the University of
Miami/Jackson Memorial Medical Center.
|
|
 |
The "New BPD"
|
|---|
Classic BPD was described in infants who had severe respiratory
distress syndrome (RDS) and received aggressive ventilation with high
positive airway pressures and inspired oxygen concentrations. The new
form of BPD occurs in smaller preterm infants, most of whom receive
antenatal steroids and postnatal surfactant therapy. Because of this
therapy, they experience a mild initial respiratory course and,
therefore, are not exposed to aggressive ventilation or high inspired
oxygen concentrations. Accordingly, the lung damage they suffer must be
caused in part by other factors.
Most of these infants have extremely low birthweights and require
prolonged ventilator support primarily for management of apnea and poor
respiratory effort. They represent more than 75% of all infants
diagnosed with CLD in our institution.
In contrast to infants who have severe BPD, these patients initially
require low concentrations of oxygen for treatment of mild RDS that
usually responds favorably to exogenous surfactant. This often is
followed by a few days during . . . [Full Text of this Article]

CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
E-Letters:
Read all E-Letters
- Restricción de líquidos
- María Graciela Barrena
- Neoreviews Online, 11 Oct 2002
[Full text]
- Response from Dr Bancalari
- Eduardo Bancalari
- Neoreviews Online, 11 Oct 2002
[Full text]
Copyright © 2000 by the American Academy of Pediatrics.